Entera Bio Ltd. (ENTX) stock
ENTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.00−0.02 (-0.66%)
Close on Nov 17, 2026Market cap $519.43MP/E –Yield –
Entera Bio market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Entera Bio's market cap was $158.71M on Nov 11, 2026, against $108.68M a year earlier. Over the last 5 years it ranged from $17.29M to $158.71M, with a median of $62.94M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $158.71M | +79.2% |
| 2025 | Dec 31, 2025 | $88.59M | +14.4% |
| 2024 | Dec 31, 2024 | $77.41M | +347.7% |
| 2023 | Dec 29, 2023 | $17.29M | -17.8% |
| 2022 | Dec 30, 2022 | $21.03M | -73.6% |
| 2021 | Dec 31, 2021 | $79.63M | +304.3% |
| 2020 | Dec 31, 2020 | $19.69M | -19.7% |
| 2019 | Dec 31, 2019 | $24.52M | +79.0% |
| 2018 | Dec 31, 2018 | $13.70M | – |
See a number that looks wrong?